SETDB1 and melanoma: As an important participator of epigenetics, aberrant methylation at H3K9 induced by the histone methyltransferase SETDB1 may contribute to tumourigenesis in breast cancer, colorectal cancer, glioma, ovarian cancer, lung cancer and melanoma [13,20,21,107].